Trial Information

Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment (DETECT)

What kind of information will DETECT provide?

I. From the cross sectional part (descriptive epidemiological part on 16th/18th September
2003)

- Frequency, characteristics and severity of cardiovascular diseases, selected associated
metabolic syndromes and atherosclerotic diseases and syndromes

- Identification and determination of the proportion of patients with high-risk
constellations (e.g., post myocardial infarction, associated morbidities, laboratory
measures)

- Rates of General Practitioners recognition, diagnostic and therapeutic profiles

- Assessment of quality of care (comparison with guidelines)

- Indicators of undertreatment, overtreatment and inadequate treatment

II. From the longitudinal part

Changes of laboratory parameters and diagnoses after one and five years, in relation to:

- Initial diagnostic and therapeutic status

- Selected intervention criteria

- Composition of risk indicators, and comparison with existing indices (PROCAM,
Framingham, Score etc.)

- Measurement of frequency and point of critical outcomes e.g., myocardial infarction,
associated morbidity, hospitalisation, critical medical interventions

- Significance of established and "new" cardiovascular risk factors

- Prognostic value of biomarkers for risk stratification